Ischemic Stroke Aspiration Systems Market Report 2025

The ischemic stroke aspiration systems market size has grown rapidly in recent years. It will grow from $0.77 billion in 2024 to $0.85 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth during the historic period can be attributed to increasing hospital investments, heightened awareness of stroke symptoms and treatment, a rising elderly population, improved accessibility to emergency medical services, and growing adoption of mechanical thrombectomy.

The ischemic stroke aspiration systems market size is expected to see strong growth in the next few years. It will grow to $1.24 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth during the forecast period can be attributed to the increasing use of aspiration systems, rising investments in healthcare infrastructure, growing preference for faster stroke recovery solutions, heightened focus on improving patient outcomes, and expanding adoption of image-guided procedures. Key trends in this period include advancements in aspiration catheter design, integration of neurovascular imaging technologies, development of robotic-assisted stroke interventions, emergence of portable stroke treatment devices, and innovations in real-time procedure monitoring systems.

The increasing prevalence of stroke risk is expected to drive the growth of the ischemic stroke aspiration systems market. Stroke risk refers to the probability of experiencing a stroke, influenced by medical conditions, lifestyle factors, and genetic predispositions. The rise in stroke risk is largely attributed to the aging population, as older individuals face higher risks due to physiological changes and an increased likelihood of conditions such as hypertension, atrial fibrillation, and atherosclerosis. Ischemic stroke aspiration systems help reduce stroke-related complications by enabling rapid and effective removal of blood clots, minimizing brain damage and improving outcomes for high-risk patients. For example, according to a report by the American College of Cardiology in August 2022, hypertension in the U.S. is projected to increase by 25.1% between 2025 and 2060, reaching approximately 162 million people, while stroke is expected to experience the largest rise among cardiovascular diseases, increasing by 33.8% to 15 million individuals. Consequently, the growing prevalence of stroke risk is driving the ischemic stroke aspiration systems market.

Leading companies in the ischemic stroke aspiration systems market are focusing on advanced clot retrieval solutions, such as first-line mechanical thrombectomy techniques, to improve procedural efficiency, patient outcomes, and speed of clot removal during acute ischemic stroke treatment. First-line mechanical thrombectomy techniques refer to the primary method used to extract blood clots from blocked cerebral arteries. For instance, in July 2025, Microvention, Inc., a U.S.-based provider of catheter-based technologies, launched the SOFIA aspiration system as a first-line technique for acute ischemic stroke, offering renowned trackability, speed, and clinical performance. The SOFIA Aspiration System combines high flexibility and a large inner lumen for efficient navigation through tortuous cerebral vessels, with a soft distal tip to reduce vessel trauma. Its optimized catheter design supports rapid recanalization with minimal device exchanges, making it particularly suited for aspiration-first approaches and enabling faster, safer clot removal in critical stroke interventions.

In April 2022, Wallaby Medical, a U.S.-based medical device company, acquired Phenox GmbH for an undisclosed sum. This acquisition allows Wallaby Medical to expand its neurovascular portfolio and strengthen its presence in the global stroke care market by leveraging Phenox’s innovative technologies and strong European footprint. Phenox GmbH is a Germany-based manufacturer specializing in ischemic stroke aspiration systems.

Major players in the ischemic stroke aspiration systems market are Johnson & Johnson, Medtronic Plc, Stryker Corporation, Terumo Corporation, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, MicroVention Inc., Penumbra Inc., Imperative Care Inc., Balt Extrusion S.A.S., Acandis GmbH, Rapid Medical Ltd., NeuroSafe Medical Co. Ltd., InNeuroCo Inc., Zylox-Tonbridge Medical Technology Co. Ltd., S3V Vascular Technologies Limited, Vesalio LLC, Wallaby Medical Inc., Kaneka Medix Corporation, and Insera Therapeutics Inc.

North America was the largest region in the ischemic stroke aspiration systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ischemic stroke aspiration systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the ischemic stroke aspiration systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Ischemic stroke aspiration systems are specialized medical devices used in the endovascular treatment of acute ischemic stroke to remove blood clots (thrombi) from blocked cerebral arteries through suction rather than mechanical retrieval. These systems involve guiding a large-bore catheter through the blood vessels to the site of the blockage in the brain, where suction is applied to remove the clot and restore blood flow.

The primary types of ischemic stroke aspiration systems include aspiration catheters, aspiration pumps, tubing and canisters, and related accessories. Aspiration catheters are thin, flexible tubes that allow physicians to remove blood clots or blockages from blood vessels, particularly during stroke treatment. These systems are used in applications such as acute ischemic stroke intervention, large vessel occlusion (LVO) treatment, thrombectomy-assisted aspiration, rescue therapy following failed stent retriever use, and the direct aspiration first pass technique (ADAPT). They serve a variety of end users, including hospitals, ambulatory surgical centers, specialty clinics, and others.

The ischemic stroke aspiration systems market research report is one of a series of new reports that provides ischemic stroke aspiration systems market statistics, including ischemic stroke aspiration systems industry global market size, regional shares, competitors with an ischemic stroke aspiration systems market share, ischemic stroke aspiration systems market segments, market trends and opportunities, and any further data you may need to thrive in the ischemic stroke aspiration systems industry. This ischemic stroke aspiration systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ischemic stroke aspiration systems market consists of sales of clot retrieval accessories, imaging and navigation systems, and disposable aspiration kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.